International knowledge centre for information resources on leprosy

Printer-friendly versionSend by email

What's New?

  1. Mycobacterium lepromatosis lepromatous leprosy in US citizen who traveled to disease-endemic areas.

    Singh AV, Chauhan DS. Emerging infectious diseases. 2018; 24(5):951-952.
    Download PDF
  2. Visual impairment and risk of depression: A longitudinal follow-up study using a national sample cohort.

    Choi HG, Lee MJ, Lee SM. Scientific reports. 2018; 8(1):2083.
    Download PDF
  3. Differential growth of Mycobacterium leprae strains (SNP genotypes) in armadillos.

    Sharma R, Singh P, Pena M, Subramanian R, Chouljenko V, Kim J, Kim N, Caskey J, Baudena MA, Adams LB, Truman RW. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2018;
  4. Mycobacterium leprae- specific antibodies in multibacillary leprosy patients decrease during and after treatment with either the regular 12 doses multi-drug therapy (MDT) or the uniform 6 doses MDT.

    Hungria EM, Bührer-Sékula S, Oliveira RM, Aderaldo LC, Pontes MA, Cruz R, Gonçalves H, Penna ML, Penna GO, Stefani MA. Frontiers in immunology. 2018;
  5. Paradigm shift in antinuclear antibody negative lupus: Current evidence.

    Tiwary AK, Kumar P. Indian journal of dermatology, venereology and leprology. 2018;

Sponsors & Partners